Population pharmacokinetics of hydroxyurea for children and adolescents with sickle cell disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Population pharmacokinetics of hydroxyurea for children and adolescents with sickle cell disease

Published:2014-04-11 Issue:9 Volume:54 Page:1016-1022
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Wiczling Paweł¹,Liem Robert I.²,Panepinto Julie A.³,Garg Uttam⁴,Abdel-Rahman Susan M.⁵,Kearns Gregory L.⁵,Neville Kathleen A.⁵

Affiliation:

1. Department of Biopharmaceutics and Pharmacokinetics; Medical University of Gdansk; Gdansk Poland

2. Hematology, Oncology & Stem Cell Transplant; Ann & Robert H. Lurie Children's Hospital of Chicago; Chicago IL

3. Pediatrics; Medical College of Wisconsin/The Children's Research Institute of the Children's Hospital of Wisconsin; Milwaukee WI

4. Department of Pathology and Laboratory Medicine; Children's Mercy Hospitals and Clinics; Kansas City MO

5. Pediatrics; Children's Mercy Hospitals and Clinics; Kansas City MO

Funder

National Heart, Lung, and Blood Institute

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jcph.303/fullpdf

Reference30 articles.

1. When should hydroxyurea be used for children with sickle cell disease?;Mueller;Pediatrics,2008

2. Hydroxyurea for children with sickle cell disease;Heeney;Pediatr Clin North Am,2008

3. Pathophysiologically based drug treatment of sickle cell disease;Steinberg;Trends Pharmacol Sci,2006

4. Functional asplenia in sickle-cell anemia;Pearson;N Engl J Med,1969

5. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia;Charache;N Engl J Med,1995

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ribonucleotide reductase as a therapeutic target for drug repurposing as anthelmintics;Experimental Parasitology;2023-12

2. Efficacy, safety, and pharmacokinetics of a new, ready-to-use, liquid hydroxyurea in children with sickle cell anemia;Blood Advances;2023-08-09

3. Effectiveness of Pharmacokinetic-Guided Hydroxyurea Dose Individualization in Patients with Sickle Cell Anemia: A Mini-Review;Pharmaceuticals;2023-06-08

4. Mathematical Modeling of Hydroxyurea Therapy in Individuals with Sickle Cell Disease;Pharmaceutics;2022-05-16

5. Compounded Nonsterile Preparations and FDA-Approved Commercially Available Liquid Products for Children: A North American Update;Pharmaceutics;2022-05-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3